Media Releases

Mr Carl Gibson, ceo of Complementary Medicines Australia (CMA) said: “We applaud the continued implementation of the government agreed recommendations from the Medicines and Medical Devices Review (MMDR), including amendments to provide a new approval pathway for listing complementary medicines with higher therapeutic indications and health claims.”


To read more click here

Complementary Medicines Australia (CMA) recently welcomed over 450 delegates and guests to Sydney for the 2017 Innovation Seminar & Supplier Expo, Annual Conference and Industry Awards.

Read the full release here

Complementary Medicines Australia (CMA) is pleased to host a Chinese delegation for this week’s industry events, the Innovation Seminar & Supplier Expo, Annual Conference and Industry Awards, held in Sydney, to showcase the capabilities of the Australian complementary medicines sector to our Chinese colleagues.

Read the full release here

Speaking today at the Complementary Medicines Australia (CMA) Innovation Seminar and Supplier Expo, Mr Carl Gibson, ceo of CMA, announced the results of the 2017 Australian Complementary Medicines Industry Audit which highlight that well-informed consumers are increasingly taking an active role in managing their health and are keen to access innovative new products.

Read the full release here

Complementary Medicines Australia (CMA) has today welcomed the exposure draft of the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 and reiterates its support of the government’s commitment to foster a regulatory environment that is supportive of innovation and competitiveness.

Read the full release here

Complementary Medicines Australia (CMA) is pleased to be welcoming a Chinese delegation to visit Australia for the upcoming CMA Innovation Seminar & Supplier Expo, Annual Conference and Industry Awards, 25-26 October 2017 in Sydney.

Read the media release here

Complementary Medicines Australia (CMA) has today congratulated Mr Richard Henfrey for his appointment as ceo of well-known industry player, Blackmores.

Read the media release here

Setting the record straight on a recent scare report about the risk of herbal medicines sold in Australia, Mr Carl Gibson, ceo of Complementary Medicines Australia (CMA) said today....

Read the media release here

Complementary Medicines Australia (CMA) has today welcomed the news that well-renowned Australian natural health company, Blackmores, has been appointed to a key leadership advisory role to the China Association for Quality Inspection (CAQI).


Read the media release here

Complementary Medicines Australia (CMA) has welcomed today’s publication of the economic report Preventive Health: How much does Australia spend and is it enough? and strongly supports the need for Australia to spend more on preventive health measures that are based on the evidence of cost effectiveness.

Read the media release here